skip to main content

Clients with major transactions routinely face shareholder and other litigation seeking to block or enforce a deal. As experienced and business-savvy litigators, we are able to fend off many such cases, often breaking new legal ground in the process.

 

Client News

QAD Defeats Preliminary Injunction Against Shareholder Vote in Challenge to Thoma Bravo Merger

Representing a special committee of the board of QAD Inc., Paul, Weiss fended off a stockholder’s preliminary injunction motion seeking to block a shareholder vote on QAD’s $2 billion merger with private equity firm Thoma Bravo.

» more

Client News

Goldman Sachs Wins Dismissal of Aiding and Abetting Claim in Delaware Chancery Court

Paul, Weiss won a victory for Goldman Sachs at the Delaware Court of Chancery, when Vice Chancellor Joseph R. Slights III dismissed a claim that Goldman aided and abetted breaches of fiduciary duty in its role as a financial advisor to Genomic Health, Inc.

» more

Publications

What SPAC Sponsors, Directors and Officers Can Do to Mitigate Their Litigation Exposure

The explosive growth in Special Purpose Acquisition Companies (SPACs) is starting to generate significant amounts of litigation. In this alert, we survey notable SPAC litigation trends and recommend what SPAC sponsors, directors and officers can do preemptively to minimize litigation exposure.

» more

Client News

Citigroup Wins Dismissal of Aiding and Abetting Claim In Delaware Chancery Court

Paul, Weiss won the dismissal of a claim that our client, Citigroup, aided and abetted alleged breaches of fiduciary duty in its role as a financial advisor to Tesaro, an oncology-focused biopharmaceutical company.

» more

Publications

Delaware Court of Chancery Finds No MAE

The Delaware Court of Chancery recently held that a dramatic 50+% reduction in the Medicare reimbursement rate for a target company’s sole product did not constitute a “Material Adverse Effect” (MAE) under the merger agreement. The court held, among other things, that the buyer failed to show that any material adverse effect on the target was “durationally significant” and that such effects did not constitute an MAE as defined in the agreement because of the specifics of the MAE definition.

» more

Client News

Symbiont Wins Victory and $70 Million Damages Award in Delaware Chancery Court

Paul, Weiss secured a resounding victory for Symbiont.io, Inc. in its lawsuit against Ipreo Holdings, LLC, IHS Markit Ltd. and certain of their affiliates in the Delaware Court of Chancery.

» more

Publications

Is the Coronavirus a Material Adverse Effect?

Currently, the impacts of the coronavirus (COVID-19) would not likely trigger the typical MAE termination right. However, this may change depending on the outbreak’s duration, disproportionate industry or company impacts and whether MAE provisions become more tailored to address this issue.  In ongoing negotiations, careful consideration should be given to crafting MAE provisions in light of the outbreak.

» more

Client News

Chancery Judge Rules Boston Scientific Must Complete Channel Medsystems Deal

Paul, Weiss won a major trial victory for client Channel Medsystems in the first case since the Delaware Supreme Court’s landmark 2018 decision in Fresenius v. Akorn to evaluate whether a merger party was justified in terminating a merger agreement on Material Adverse Event (MAE) grounds.

» more

Client News

In Landmark Victory, Delaware Supreme Court Affirms that Fresenius Can Terminate Akorn Deal

Paul, Weiss secured a landmark victory for German healthcare group Fresenius SE & Co. when the Delaware Supreme Court affirmed that Fresenius was justified in canceling its $4.8 billion agreement to acquire Illinois-based Akorn, Inc.

» more

Awards & Recognition

The American Lawyer Names Andrew Gordon and Jaren Janghorbani “Litigators of the Week”

Litigation partners Andrew Gordon and Jaren Janghorbani were named “Litigators of the Week” by The American Lawyer in recognition of their trial victory for Channel Medsystems in a high-stakes merger litigation in Delaware.

» more

© 2021 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy